Sunway Healthcare's Initial Public Offering (IPO) is set to be a game-changer, with sources revealing that it could raise a staggering RM2.86 billion. This ambitious move by Sunway Healthcare Holdings Bhd (SHH) is poised to set a new record for funds raised in a Bursa Malaysia listing, surpassing the previous benchmark set by 99 Speed Mart Retail Holdings Bhd's IPO last year. But here's where it gets controversial... Some industry experts argue that the high valuation sought by Sunway, up to RM16 billion, might be a stretch, especially with a price-earnings ratio (PER) of 55.4 times its estimated earnings for FY2026 and 39.7 times its FY2027 forecast. This valuation, they suggest, could be a potential red flag for investors. And this is the part most people miss... Despite the potential risks, Sunway Healthcare's IPO is gaining traction due to the scarcity of demand and the major shareholder's determination to build a healthcare brand from the ground up. The healthcare sector is generally seen as resilient, with steady demand, the ability to adjust prices, and high barriers to entry. Private hospital groups are focusing on higher-margin specialist services, digital systems, and efficient infrastructure to boost profitability. SHH's IPO comprises an offer for sale of up to 1.39 billion existing shares and a public issue of 575 million new shares. The proceeds from the new shares will primarily fund capital expenditure for hospital expansion and new facility development in Iskandar Puteri, Johor; Putrajaya; and Seremban. These projects aim to increase SHH's total licensed bed capacity to over 3,400 beds by 2032, effectively doubling its scale over the next decade. Post-listing, Sunway, through its subsidiary Sunway City Sdn Bhd (SunCity), will retain control with a 69.5% stake, while Singapore's sovereign wealth fund GIC will reduce its shareholding to 7.5%. SHH's financial performance is impressive, with revenue of RM1.85 billion and a net profit of RM257.5 million for FY2024, up from RM1.46 billion and RM181.63 million, respectively, in FY2023. However, the question remains: Will the market support the high valuation sought by Sunway Healthcare? It's a thought-provoking question that invites discussion and debate. Will the IPO be a success, or will it face challenges in the market? The answer lies in the hands of investors and the market's perception of Sunway Healthcare's potential.
